[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2626 followers Created: 2025-07-18 16:04:42 UTC $RHHBY Genentech updates on FDA application for Columvi combo for patients with relapsed or refractory Diffuse Large B-cell Lymphoma. More Info: $XBI $IBB $XPH $PPH  XXXXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [combo](/topic/combo) [$rhhby](/topic/$rhhby) [Post Link](https://x.com/OzmosiHealth/status/1946239716480963035)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2626 followers
Created: 2025-07-18 16:04:42 UTC
$RHHBY Genentech updates on FDA application for Columvi combo for patients with relapsed or refractory Diffuse Large B-cell Lymphoma.
More Info: $XBI $IBB $XPH $PPH
XXXXX engagements
/post/tweet::1946239716480963035